Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4521 publications
Effects of Dapagliflozin on Left Atrial Ejection Force in Heart Failure with Preserved Ejection Fraction: DAPA-Left Atrial Ejection Force Trial.
Journal: Anatolian journal of cardiology
Published: October 20, 2025
Sintilimab-related fulminant autoimmune diabetes mellitus manifesting as diabetic ketoacidosis and rare insulin resistance: A case report and literature review.
Journal: Endocrine journal
Published: October 13, 2025
SGLT-2 Inhibitors After Acute Coronary Syndrome: A Preventive Approach for Heart Failure-Related Complications: A Meta-Analysis.
Journal: American journal of therapeutics
Published: October 09, 2025
Pilot study on the effects of dapagliflozin on echocardiographic parameters in dogs with symptomatic myxomatous mitral valve disease.
Journal: Veterinary and animal science
Published: October 06, 2025
Correction: Dapagliflozin protects against doxorubicin-induced cardiotoxicity by restoring STAT3.
Journal: Archives of toxicology
Published: October 03, 2025
Dapagliflozin: A new frontier in mitochondrial cardioprotection.
Journal: Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology
Published: September 19, 2025
Effect of dapagliflozin on proteinuria and the slope of the estimated glomerular filtration rate in patients with immunoglobulin A nephropathy: A multicenter prospective study.
Journal: The Journal of international medical research
Published: September 18, 2025
Dapagliflozin attenuates lipotoxic tenocyte injury via PPARα activation and irisin-driven antioxidant pathways.
Journal: Connective tissue research
Published: September 17, 2025
EXPRESS: Association Between Dapagliflozin Use and Coronary Collateral Circulation in Patients with Type 2 Diabetes: A Hypothesis-Generating Study.
Journal: Journal of investigative medicine : the official publication of the American Federation for Clinical Research
Published: September 15, 2025
Dapagliflozin reduces proteinuria in IgA nephropathy patients receiving immunosuppressive therapy.
Journal: Renal failure
Published: September 10, 2025
Composite endpoints in health technology assessment: part 2 - expanding the evidence base with a framework for best modeling practice.
Journal: Journal of comparative effectiveness research
Published: September 10, 2025
Last Updated: 10/31/2025